100 related articles for article (PubMed ID: 26553360)
1. miR-339-5p inhibits migration and invasion in ovarian cancer cell lines by targeting NACC1 and BCL6.
Shan W; Li J; Bai Y; Lu X
Tumour Biol; 2016 Apr; 37(4):5203-11. PubMed ID: 26553360
[TBL] [Abstract][Full Text] [Related]
2. TTK (threonine tyrosine kinase) regulates the malignant behaviors of cancer cells and is regulated by microRNA-582-5p in ovarian cancer.
Lu N; Ren L
Bioengineered; 2021 Dec; 12(1):5759-5768. PubMed ID: 34516342
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-10a-5p-mediated downregulation of GATA6 inhibits tumor progression in ovarian cancer.
Gao F; Wu Q; Lu D
Hum Cell; 2024 Jan; 37(1):271-284. PubMed ID: 37768544
[TBL] [Abstract][Full Text] [Related]
4. miR-152 is involved in the proliferation and metastasis of ovarian cancer through repression of ERBB3.
Li LW; Xiao HQ; Ma R; Yang M; Li W; Lou G
Int J Mol Med; 2018 Mar; 41(3):1529-1535. PubMed ID: 29286064
[TBL] [Abstract][Full Text] [Related]
5. LINC00707 promotes multidrug resistance of ovarian cancer cells by targeting the miR-382-5p/LRRK2 axis.
Zhao MW; Lin CJ; Qiu JP
Acta Biochim Pol; 2023 Oct; 70(4):799-806. PubMed ID: 37788370
[TBL] [Abstract][Full Text] [Related]
6. BUB1, BUB1B, CCNA2, and CDCA8, along with miR-524-5p, as clinically relevant biomarkers for the diagnosis and treatment of endometrial carcinoma.
Hao Q; Wu H; Liu E; Wang L
BMC Cancer; 2023 Oct; 23(1):995. PubMed ID: 37853361
[TBL] [Abstract][Full Text] [Related]
7. Methylation-mediated repression of MiR-424/503 cluster promotes proliferation and migration of ovarian cancer cells through targeting the hub gene KIF23.
Li T; Li Y; Gan Y; Tian R; Wu Q; Shu G; Yin G
Cell Cycle; 2019 Jul; 18(14):1601-1618. PubMed ID: 31135262
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of TMEM14A expression by RNAi inhibits the proliferation and invasion of human ovarian cancer cells.
Zhang Q; Chen X; Zhang X; Zhan J; Chen J
Biosci Rep; 2016; 36(1):e00298. PubMed ID: 26896463
[TBL] [Abstract][Full Text] [Related]
9. Tumour-suppressor microRNAs regulate ovarian cancer cell physical properties and invasive behaviour.
Chan CK; Pan Y; Nyberg K; Marra MA; Lim EL; Jones SJ; Maar D; Gibb EA; Gunaratne PH; Robertson AG; Rowat AC
Open Biol; 2016 Nov; 6(11):. PubMed ID: 27906134
[TBL] [Abstract][Full Text] [Related]
10. An overview of the co-transcription factor NACC1: Beyond its pro-tumor effects.
Xie Q; Tong C; Xiong X
Life Sci; 2024 Jan; 336():122314. PubMed ID: 38030057
[TBL] [Abstract][Full Text] [Related]
11. Selectively targeting BCL6 using a small molecule inhibitor is a potential therapeutic strategy for ovarian cancer.
Wu M; Xie J; Xing Y; Zhang L; Chen H; Tang B; Zhou M; Lv S; Huang D; Jian S; Zhou C; Liu M; Guo W; Chen Y; Yi Z
Int J Biol Sci; 2024; 20(2):486-501. PubMed ID: 38169532
[TBL] [Abstract][Full Text] [Related]
12. Tumor-derived exosomal circRNA051239 promotes proliferation and migration of epithelial ovarian cancer.
Ma R; Ye X; Cheng H; Cui H; Chang X
Am J Transl Res; 2021; 13(3):1125-1139. PubMed ID: 33841644
[TBL] [Abstract][Full Text] [Related]
13. Antiandrogen Flutamide-Induced Restoration of miR-449 Expression Mitigates Functional Biomarkers Associated with Ovarian Cancer Risk.
Wang X; Woo HH; Wei M; Gibson S; Miranda M; Rush D; Cragun J; Zheng W; Yao G; Chambers SK
medRxiv; 2024 Feb; ():. PubMed ID: 38464045
[TBL] [Abstract][Full Text] [Related]
14. The roles of FXYD family members in ovarian cancer: an integrated analysis by mining TCGA and GEO databases and functional validations.
Zhao E; Gao K; Xiong J; Liu Z; Chen Y; Yi L
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17269-17284. PubMed ID: 37814066
[TBL] [Abstract][Full Text] [Related]
15. Cross talk of tumor protein D52 (TPD52) with KLF9, PKCε, and MicroRNA 223 in ovarian cancer.
Khan K; Zafar S; Badshah Y; Ashraf NM; Rafiq M; Danish L; Shabbir M; Trembley JH; Afsar T; Almajwal A; Razak S
J Ovarian Res; 2023 Oct; 16(1):202. PubMed ID: 37833790
[TBL] [Abstract][Full Text] [Related]
16. Contribution of sphingomyelin phosphodiesterase acid-like 3B to the proliferation, migration, and invasion of ovarian cancer cells.
Song B; Jiang Y; Lin Y; Liu J; Jiang Y
Transl Cancer Res; 2024 Apr; 13(4):1954-1968. PubMed ID: 38737677
[TBL] [Abstract][Full Text] [Related]
17. Multimerin 1 aids in the progression of ovarian cancer possibly via modulation of DNA damage response and repair pathways.
Saini A; Kumar V; Tomar AK; Sharma A; Yadav S
Mol Cell Biochem; 2023 Oct; 478(10):2395-2403. PubMed ID: 36723821
[TBL] [Abstract][Full Text] [Related]
18. Nacc1 Mutation in Mice Models Rare Neurodevelopmental Disorder with Underlying Synaptic Dysfunction.
Deehan MA; Kothuis JM; Sapp E; Chase K; Ke Y; Seeley C; Iuliano M; Kim E; Kennington L; Miller R; Boudi A; Shing K; Li X; Pfister E; Anaclet C; Brodsky M; Kegel-Gleason K; Aronin N; DiFiglia M
J Neurosci; 2024 Apr; 44(14):. PubMed ID: 38388424
[TBL] [Abstract][Full Text] [Related]
19. Hyperkinetic Movement Disorder Caused by the Recurrent c.892C>T NACC1 Variant.
Komulainen-Ebrahim J; Kangas SM; López-Martín E; Feyma T; Scaglia F; Martínez-Delgado B; Kuismin O; Suo-Palosaari M; Carr L; Hinttala R; Kurian MA; Uusimaa J
Mov Disord Clin Pract; 2024 May; ():. PubMed ID: 38698576
[TBL] [Abstract][Full Text] [Related]
20. Expression of Concern: Knockdown of TMEM14A expression by RNAi inhibits the proliferation and invasion of human ovarian cancer cells.
Biosci Rep; 2023 Feb; 43(2):. PubMed ID: 36756748
[No Abstract] [Full Text] [Related]
[Next] [New Search]
